198) Disease severity was assessed using the Ps |
199) verity of genital involvement and overall disease severity and body mass index. |
200) stigate changes in quality of life (QoL), disease severity and exercise tolerance of |
201) ransition probabilities between states of disease severity are inferred indirectly f |
202) Even in the presence of disease severity in patients with New York |
203) Health related QoL, disease severity measured by B-type natriu |
204) f severe impact of psoriasis on HRQoL was disease severity. |
205) s current statistical inference regarding disease progression and cognitive function |
206) histologically disparate but show similar disease progression and response to therap |
207) hese dogs, but none of the others, showed disease progression. |
208) sm by which these proteases contribute to disease progression. |
209) concerned the involvement of bacteria in disease progression. |
210) oglia subtypes with peculiar functions in disease progression. |
211) erging zoonotic mosquito-borne infectious disease that has been identified as a risk |
212) Asthma is a highly prevalent disease that may affect the lifestyle adop |
213) Rhabdomyosarcoma is a disease that predominantly affects childre |
214) e myeloid leukemia (AML) is an aggressive disease that predominantly affects elderly |
215) t of an infant with microvillus inclusion disease that presented with bowel "dissect |
216) etween work history and interstitial lung disease that strengths the presumption to |
217) Female disease was at least as severe as male dis |
218) Local disease was controlled; unfortunately, met |
219) The disease was diagnosed 10 years ago based o |
220) Metastatic disease was identified in 2 of 12 lymph no |
221) of snail intermediate hosts, emergence of disease was just a matter of time. |
222) Autosomal recessive inheritance of this disease was supported in our cases because |
223) s (NCDs) such as diabetes, cardiovascular disease (CVD) and chronic kidney disease ( |
224) es of young and old RBC in chronic venous disease (CVD) patients. |
225) daily steps and changes in cardiovascular disease (CVD) risk factors in a year-long |
226) the contribution of actual cardiovascular disease (CVD) risks, psychosocial and work |
227) survivors against that of cardiovascular disease (CVD) survivors. |
228) ther individuals presenting inflammation (disease-positive or D+) can be distinguish |
229) PAF estimates the proportion of the disease or condition that would not occur |
230) are different manifestations of the same disease or if these conditions are in some |
|